OpenURL Connection Search

Select item for more details and to access through your institution.

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
Published in:
EMBO Molecular Medicine, 2013, v. 5, n. 8, p. 1180, doi. 10.1002/emmm.201202034
By:
- Emadali, Anouk;
- Rousseaux, Sophie;
- Bruder‐Costa, Juliana;
- Rome, Claire;
- Duley, Samuel;
- Hamaidia, Sieme;
- Betton, Patricia;
- Debernardi, Alexandra;
- Leroux, Dominique;
- Bernay, Benoit;
- Kieffer‐Jaquinod, Sylvie;
- Combes, Florence;
- Ferri, Elena;
- McKenna, Charles E.;
- Petosa, Carlo;
- Bruley, Christophe;
- Garin, Jérôme;
- Ferro, Myriam;
- Gressin, Rémy;
- Callanan, Mary B.
Publication type:
Article
1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 5, p. 159, doi. 10.1002/emmm.201000067
By:
- Fournier, Alexandra;
- McLeer-Florin, Anne;
- Lefebvre, Christine;
- Duley, Samuel;
- Barki, Leila;
- Ribeyron, Juliana;
- Alboukadel, Kassambara;
- Hamaidia, Sieme;
- Granjon, Aurélie;
- Gressin, Rémy;
- Lajmanovich, Alicia;
- Bonnefoix, Thierry;
- Chauvelier, Stéphanie;
- Debernardi, Alexandra;
- Rousseaux, Sophie;
- de Fraipont, Florence;
- Figeac, Martin;
- Kerckaert, Jean-Pierre;
- De Vos, John;
- Usson, Yves
Publication type:
Article
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.
Published in:
Cancers, 2021, v. 13, n. 23, p. 5900, doi. 10.3390/cancers13235900
By:
- Bouroumeau, Antonin;
- Bussot, Lucile;
- Hamaidia, Sieme;
- Garcìa-Sandoval, Andrea;
- Bergan-Dahl, Anna;
- Betton-Fraisse, Patricia;
- Duley, Samuel;
- Fournier, Cyril;
- Aucagne, Romain;
- Adrait, Annie;
- Couté, Yohann;
- McLeer, Anne;
- Col, Edwige;
- David-Boudet, Laurence;
- Raskovalova, Tatiana;
- Jacob, Marie-Christine;
- Vettier, Claire;
- Chevalier, Simon;
- Carras, Sylvain;
- Lefebvre, Christine
Publication type:
Article
Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
Published in:
British Journal of Haematology, 2012, v. 158, n. 2, p. 186, doi. 10.1111/j.1365-2141.2012.09161.x
By:
- Gimenez, Estelle;
- Chauvet, Martine;
- Rabin, Laetitia;
- Puteaud, Isabelle;
- Duley, Samuel;
- Hamaidia, Sieme;
- Bruder, Juliana;
- Rolland-Neyret, Valérie;
- Gouill, Steven;
- Tournilhac, Olivier;
- Voog, Eric;
- Maisonneuve, Hervé;
- Jacob, Marie C.;
- Leroux, Dominique;
- Béné, Marie C.;
- Formisano-Tréziny, Christine;
- Gabert, Jean;
- Gressin, Rémy;
- Callanan, Mary B.
Publication type:
Article
Enantioselective Approach for Expanding the Three‐Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors**.
Published in:
Chemistry - A European Journal, 2022, v. 28, n. 64, p. 1, doi. 10.1002/chem.202202293
By:
- Lespinasse, Marie‐Ange;
- Wei, Kaiyao;
- Perrin, Justine;
- Winkler, Matthias;
- Hamaidia, Sieme;
- Leroy, Alexis;
- Macek Jilkova, Zuzana;
- Philouze, Christian;
- Marche, Patrice N.;
- Petosa, Carlo;
- Govin, Jérôme;
- Emadali, Anouk;
- Wong, Yung‐Sing
Publication type:
Article

Found: 5

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma.

CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.

Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.

Enantioselective Approach for Expanding the Three‐Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors**.